Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy

Background: Estimating distant recurrence (DR) risk among women with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2 (HER2)–negative early breast cancer helps decisions on using adjuvant chemotherapy. The 21-gene Oncotype DX recurrence score (RS) is widely used for this. E...

Full description

Saved in:
Bibliographic Details
Published in:J Natl Cancer Inst
Main Authors: Buus, Richard, Sestak, Ivana, Kronenwett, Ralf, Denkert, Carsten, Dubsky, Peter, Krappmann, Kristin, Scheer, Marsel, Petry, Christoph, Cuzick, Jack, Dowsett, Mitch
Format: Artigo
Language:Inglês
Published: Oxford University Press 2016
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241904/
https://ncbi.nlm.nih.gov/pubmed/27400969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw149
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items